Sumitomo Pharma Co., Ltd. (4506.T)
JPY 575.0
(-0.69%)
JPY 575.0
(-0.69%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -241.89 Billion | 11.93 Billion | 31.23 Billion | 135.6 Billion | 46.12 Billion | 48.71 Billion |
| Net Income | -314.96 Billion | -96.71 Billion | 40.6 Billion | 36.82 Billion | 35.91 Billion | 48.62 Billion |
| Depreciation & Amortization | 37.76 Billion | 41.26 Billion | 38.34 Billion | 22.67 Billion | 17.36 Billion | 13.97 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -95.84 Billion | 34.87 Billion | -33.73 Billion | 66.32 Billion | -20.85 Billion | -13.82 Billion |
| Other non-cash items | 189.44 Billion | 32.51 Billion | -13.97 Billion | 9.77 Billion | 13.69 Billion | -69 Million |
| Investing Cash Flow | 33.03 Billion | 52.41 Billion | -18.27 Billion | 8.87 Billion | -312.68 Billion | -35.04 Billion |
| Investments in PPE | -15.73 Billion | -12.74 Billion | -13.49 Billion | -10.8 Billion | -13.35 Billion | -12.91 Billion |
| Acquisitions | 9.03 Billion | 30.17 Billion | -3.7 Billion | 15.92 Billion | -205.77 Billion | 1.69 Billion |
| Investment purchases | -4.77 Billion | -6.24 Billion | -25.9 Billion | -9.36 Billion | -112.49 Billion | -2.77 Billion |
| Sales/Maturities of investments | 34.49 Billion | 10.06 Billion | 19.47 Billion | 8.14 Billion | 1.62 Billion | -1.69 Billion |
| Other Investing Activities | 10 Billion | 31.16 Billion | 5.35 Billion | 4.98 Billion | 17.31 Billion | -19.35 Billion |
| Financing Cash Flow | 77.85 Billion | -146.81 Billion | -21.42 Billion | -57.21 Billion | 231.08 Billion | -28.64 Billion |
| Debt repayment | -84 Billion | -20.06 Billion | -4.96 Billion | -2.96 Billion | -19.62 Billion | -12.96 Billion |
| Dividends payments | -2.79 Billion | -11.12 Billion | -11.12 Billion | -11.12 Billion | -13.1 Billion | -11.12 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 659 Million | -115.63 Billion | -5.34 Billion | -43.13 Billion | 263.81 Billion | -4.56 Billion |
| Accounts receivables | 23.39 Billion | 51.21 Billion | -6.09 Billion | 185 Million | -16.37 Billion | -3.63 Billion |
| Accounts payables | 5.64 Billion | 5.31 Billion | -28.66 Billion | -320 Million | 15.24 Billion | -10.86 Billion |
| Inventory | -11.79 Billion | 4.56 Billion | 5.35 Billion | -10.03 Billion | -14.35 Billion | -3.2 Billion |
| Other working capital | -113.08 Billion | -26.21 Billion | -4.32 Billion | 76.5 Billion | -5.36 Billion | 3.88 Billion |
| Cash at beginning of period | 143.47 Billion | 202.98 Billion | 193.69 Billion | 101.7 Billion | 137.29 Billion | 147.77 Billion |
| Cash at end of period | 29.04 Billion | 143.47 Billion | 202.98 Billion | 193.69 Billion | 101.7 Billion | 137.29 Billion |
| Capital Expenditure | -15.73 Billion | -12.74 Billion | -13.49 Billion | -10.8 Billion | -13.35 Billion | -12.91 Billion |
| Effect of forex changes on cash | 15.44 Billion | 24.09 Billion | 17.75 Billion | 4.72 Billion | -113 Million | 4.5 Billion |
| Net cash flow / Change in cash | -114.43 Billion | -59.5 Billion | 9.28 Billion | 91.99 Billion | -35.58 Billion | -10.47 Billion |
| Free Cash Flow | -257.62 Billion | -805 Million | 17.74 Billion | 124.79 Billion | 32.77 Billion | 35.79 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -48.16 Billion | 15.93 Billion | -314.96 Billion | -197.26 Billion | -49.96 Billion | -28.87 Billion |
| Depreciation & Amortization | 6.78 Billion | 6.9 Billion | 37.76 Billion | 9.5 Billion | 9.6 Billion | 9.44 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 59.15 Billion | 27.89 Billion | -95.84 Billion | 15.13 Billion | -25.6 Billion | 7.06 Billion |
| Other non-cash items | 11.83 Billion | -75.79 Billion | 189.44 Billion | 154.9 Billion | 9.73 Billion | -31.96 Billion |
| Investing Cash Flow | -4.67 Billion | 102.12 Billion | 33.03 Billion | -5.3 Billion | 5.66 Billion | -5.78 Billion |
| Investments in PPE | -1.76 Billion | -2.3 Billion | -15.73 Billion | -4.83 Billion | -2.45 Billion | -4.16 Billion |
| Acquisitions | 27 Million | 997 Million | 9.03 Billion | -2.45 Billion | 38 Million | 2.45 Billion |
| Investment purchases | -382 Million | -638 Million | -4.77 Billion | -662 Million | -590 Million | -2.03 Billion |
| Sales/Maturities of investments | 293 Million | 105.41 Billion | 34.49 Billion | 2.65 Billion | 8.67 Billion | 354 Million |
| Other Investing Activities | - | 104.42 Billion | 10 Billion | 1.44 Billion | 7.9 Billion | -2.39 Billion |
| Financing Cash Flow | -192 Million | -29.24 Billion | 77.85 Billion | 5.73 Billion | 27.31 Billion | 11.23 Billion |
| Debt repayment | -441 Million | -550 Million | -84 Billion | -7 Billion | -28 Billion | -11.97 Billion |
| Dividends payments | - | -1 Million | -2.79 Billion | -1 Million | -6 Million | -49 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -633 Million | -28.69 Billion | 659 Million | 163 Million | 55.32 Billion | 23.25 Billion |
| Accounts receivables | 1.69 Billion | 11.34 Billion | 23.39 Billion | 18.65 Billion | -3.13 Billion | 3.11 Billion |
| Accounts payables | 5.94 Billion | -12.17 Billion | 5.64 Billion | 13 Billion | -5.24 Billion | 8.88 Billion |
| Inventory | 4.03 Billion | 3.52 Billion | -11.79 Billion | -6.08 Billion | -1.7 Billion | -3.27 Billion |
| Other working capital | 47.48 Billion | 13.02 Billion | -113.08 Billion | -10.42 Billion | -15.52 Billion | -1.67 Billion |
| Cash at beginning of period | 78.39 Billion | 29.04 Billion | 143.47 Billion | 36.45 Billion | 60.39 Billion | 94.47 Billion |
| Cash at end of period | 99.08 Billion | 78.39 Billion | 29.04 Billion | 29.04 Billion | 36.45 Billion | 60.39 Billion |
| Capital Expenditure | -1.76 Billion | -2.3 Billion | -15.73 Billion | -4.83 Billion | -2.45 Billion | -4.16 Billion |
| Effect of forex changes on cash | - | 1.52 Billion | 15.44 Billion | 3.32 Billion | -690 Million | 4.81 Billion |
| Net cash flow / Change in cash | 20.68 Billion | 49.35 Billion | -114.43 Billion | -7.41 Billion | -23.94 Billion | -34.07 Billion |
| Free Cash Flow | 27.84 Billion | -27.35 Billion | -257.62 Billion | -16 Billion | -58.68 Billion | -48.5 Billion |
1376
TRANSFRE
EMMESSA
3353
VIVHY
FCAFF